•  
  •  
  •  
  •  

2025-12-24 22:30:29

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Deepak Mining Solutions Ltd to acquire 100% in Explosives Manufacturer
  • BharatRohan Airborne Innovations secures DGCA Type Certification for 'Pravir-X6', Advancing Sustainable Farm Mechanization
  • Karnataka HC sets aside IT assessment order with demand of Rs. 779.56 Mn against Aequs Limited
  • Silicon Rental Solutions Ltd receives order from Techfruits Solutions Pvt Ltd
  • Royal Orchid Hotels Strengthens Central India Portfolio with New Signing in Gwalior, Madhya Pradesh

Keywords Selected:  Pharmaceuticals

Research

  • Kotak Institutional Equities - Pharmaceuticals: IPM pulse - gaining momentum
  • Company Update - P&G Health - ICICI Direct
  • Quant Pick - Cadila Healthcare - ICICI Direct
  • Q2FY22 Result Update - Syngene International - ICICI Direct
  • Syngene International Ltd - Lack of near term triggers - YES Securities
  • Syngene International Ltd - Lower gross margin lead to EBIDTA miss - YES Securities

IPO News

  • Accretion Pharmaceuticals' IPO Opens for subscription today, Price Band set at ₹96-101 per Share
  • Accretion Pharmaceuticals Ltd IPO to open for subscription on May 14, 2025
  • Senores Pharmaceuticals IPO subscribed 13.93 times on Day 2
  • Senores Pharmaceuticals IPO fully subscribed on Day 1
  • Senores Pharmaceuticals gets Sebi nod for IPO

Stock Report

  • Strides Pharma Inc's Chestnut Ridge facility gets 4 observations from USFDA
  • Fermenta ranked among India's Best Workplaces™ in Pharmaceuticals, Healthcare & Biotech by Great Place to Work®
  • Zydus partners with Bioeq for U.S. Commercialisation rights for NUFYMCO®, an Interchangeable Biosimilar to Lucentis®
  • Ajanta signs in-licensing agreement with Biocon for marketing Semaglutide in 26 countries
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial
  • CORONA Remedies Ltd commissions additional capacity
  • Shukra Pharmaceuticals Ltd receives authorization from Univlabs Technologies Pvt. Ltd.
  • Emcure expands weight management therapy access with Launch of Poviztra®
  • Sai Life Sciences Releases Sustainability Report 2024-25
  • Pfizer & Cipla announce Exclusive Marketing and Distribution Partnership for Select Brands in India
  • Zydus Lifesciences Limited signs an exclusive agreement with Myriad Genetics of US to launch cancer-risk assessment diagnostic tests in India
  • Lupin signs exclusive licensing agreement with Neopharmed for Gastroenterology Brand Plasil® in the Philippines and Brazil
  • Alembic Pharmaceuticals Limited announces USFDA Final Approval for Travoprost Ophthalmic Solution USP, 0.004%
  • APL Healthcare Ltd's Unit-4 gets 5 observations from USFDA
  • US FDA determines Sun Pharma's Baska facility inspection classification as OAI
  • AstraZeneca Pharma India Ltd receives permission from CDSCO for Datopotamab Deruxtecan powder
  • Lupin receives Positive CHMP Opinion for Biosimilar Ranibizumab
  • Lupin receives EIR from US FDA for its Nagpur Injectable Facility
  • Glenmark Secures Exclusive Multi-Regional Rights to Aumolertinib, an MHRA and NMPA approved Third-Generation EGFR-TKI, from Hansoh Pharma
  • Shelter Pharma Ltd secures order
  • Lupin Secures SBTi Validation for Emission Reduction Targets
  • Glenmark Secures Exclusive Multi-Regional Rights to Aumolertinib, an MHRA and NMPA approved Third-Generation EGFR-TKI, from Hansoh Pharma
  • Akums introduces enhanced Gabapentin ER Formulation powered by RetenEx Technology for PHN Management
  • Sentynl Therapeutics Announces FDA Acceptance of CUTX-101 NDA Resubmission

Industry News

  • NYSE Listed Amneal Pharmaceuticals begins Commercial Operations in India

Latest Post

  • Deepak Mining Solutions Ltd to acquire 100% in Explosives Manufacturer
  • BharatRohan Airborne Innovations secures DGCA Type Certification for 'Pravir-X6', Advancing Sustainable Farm Mechanization
  • Karnataka HC sets aside IT assessment order with demand of Rs. 779.56 Mn against Aequs Limited
  • Silicon Rental Solutions Ltd receives order from Techfruits Solutions Pvt Ltd
  • Royal Orchid Hotels Strengthens Central India Portfolio with New Signing in Gwalior, Madhya Pradesh


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024